Status:

UNKNOWN

China Cimicifuga Trial of Climacteric Complaint Control

Lead Sponsor:

Shandong Luye Pharmaceutical Co., Ltd.

Conditions:

Climacteric Symptoms

Eligibility:

FEMALE

40-60 years

Phase:

PHASE4

Brief Summary

This study is designed to determine whether an extract of Cimicifuga Foetida L. is safe and efficacious to relieve the climacteric symptoms of Chinese women

Detailed Description

Extracts of Cimicifuga Racemosa (black cohosh) have been widely used in North America and Europe for decades for the treatment of menopause related problems, either as nutritional supplements or as ph...

Eligibility Criteria

Inclusion

  • Having climacteric symptoms with hot flushes \>= 3 time per day
  • Score of Kupperman Index at baseline \>= 20
  • In addition to these criteria, women who had menopause longer than 2 months but less than 12 months, with FSH \> 15U/L were enrolled into the perimenopausal group. Women having menopause longer than 12 months but less than 5 years, with FSH \>= 40U/L and E2 \<= 30pg/ml, were assigned into early staged postmenopausal group.

Exclusion

  • Having history of hysterectomy
  • Having HRT within 6 weeks
  • Having other drugs or nutritional supplements of relieving climacteric symptoms within one week
  • Having psychological counseling within one week
  • Having medical history of estrogen-dependent tumors
  • The result of pap smear exam at stage III and above
  • Having an uterine leiomyoma lager than 4 cm
  • The endometrial thickness lager than 0.5 cm
  • Having abnormal cardiac, liver or kidney functions
  • Having abnormal thyroid function
  • Having hypertension, diabetes and coronary heart diseases that were not under control
  • Pregnant or suspected pregnant woman
  • Having severe mental disorders that inhibit to understand the research purpose
  • Other conditions the investigators believed not suitable for enrollment

Key Trial Info

Start Date :

February 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

February 1 2009

Estimated Enrollment :

288 Patients enrolled

Trial Details

Trial ID

NCT00622986

Start Date

February 1 2008

End Date

February 1 2009

Last Update

February 25 2008

Active Locations (13)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 4 (13 locations)

1

Fujian Provincal Maternal and Children Health Hospital

Fuzhou, Fujian, China, 350001

2

The First Affiliated Hospital,SUN YAT-SEN University

Guangzhou, Guangdong, China, 510080

3

Zhongnan University Xiangya No.3. Hospital

Changsha, Hunan, China, 410013

4

Zhongnan University Xiangya No.2. Hospital

Changsha, Hunnan, China, 410011